BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 19187865)

  • 1. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
    Chevaliez S; Pawlotsky JM
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening and diagnosis of hepatitis B and C].
    Chevaliez S; Pawlotsky JM
    Rev Prat; 2005 Mar; 55(6):615-23. PubMed ID: 15913113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological techniques for the diagnosis and monitoring of hepatitis B and C.
    Chevaliez S; Pawlotsky JM
    Ann Hepatol; 2009; 8(1):7-12. PubMed ID: 19221527
    [No Abstract]   [Full Text] [Related]  

  • 5. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Features of combined (HBV/HCV-infection) viral lesion of the liver].
    Maev IV; Nikushkina IN; Samsonov AA; Aksel'rod AG
    Ter Arkh; 2008; 80(2):57-61. PubMed ID: 18372598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V
    Acta Med Croatica; 2005; 59(5):413-7. PubMed ID: 16381236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
    Martín-Carbonero L; Barreiro P; Jiménez-Galán G; García-Berriguete R; Núñez M; Ríos P; González-Lahoz J; Soriano V
    J Viral Hepat; 2007 Jun; 14(6):392-5. PubMed ID: 17501759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
    Fournier C; Zoulim F
    Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage.
    Carabaich A; Ruvoletto M; Bernardinello E; Tono N; Cavalletto L; Chemello L; Gatta A; Pontisso P
    J Med Virol; 2005 May; 76(1):55-60. PubMed ID: 15778969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B: modern end points of treatment and the specter of viral resistance.
    Lee M; Keeffe EB
    Gastroenterol Clin North Am; 2011 Sep; 40(3):495-505. PubMed ID: 21893270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to use virological tools for optimal management of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    Liver Int; 2009 Jan; 29 Suppl 1():9-14. PubMed ID: 19207960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic diagnosis of hepatitis B and C].
    Gervain J
    Orv Hetil; 2003 Dec; 144(52):2547-52. PubMed ID: 15005063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients].
    Nicolardi E; Grieco A; Rapaccini GL; Pompili M
    G Ital Nefrol; 2010; 27(3):262-73. PubMed ID: 20540019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B.
    Hellström U; Lindh M; Krogsgaard K; Sylvan S
    J Gastroenterol Hepatol; 2008 May; 23(5):804-10. PubMed ID: 17931371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
    Borgniet O; Parvaz P; Bouix C; Chevallier P; Trépo C; André P; Zoulim F
    J Med Virol; 2009 Aug; 81(8):1336-42. PubMed ID: 19551826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological tools to diagnose and monitor hepatitis C virus infection.
    Chevaliez S
    Clin Microbiol Infect; 2011 Feb; 17(2):116-21. PubMed ID: 21054664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.